Crisis of confidence averted: Impairment of exercise economy and performance in elite race walkers by ketogenic low carbohydrate, high fat (LCHF) diet is reproducible.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

Athletic Performance* ; Diet, High-Fat* ; Diet, Ketogenic* ; Physical Conditioning, Human*/methods ; Walking*; Adaptation, Physiological ; Athletes ; Female ; Humans ; Male ; Physical Endurance

Introduction: We repeated our study of intensified training on a ketogenic low-carbohydrate (CHO), high-fat diet (LCHF) in world-class endurance athletes, with further investigation of a "carryover" effect on performance after restoring CHO availability in comparison to high or periodised CHO diets.
Methods: After Baseline testing (10,000 m IAAF-sanctioned race, aerobic capacity and submaximal walking economy) elite male and female race walkers undertook 25 d supervised training and repeat testing (Adapt) on energy-matched diets: High CHO availability (8.6 g∙kg-1∙d-1 CHO, 2.1 g∙kg-1∙d-1 protein; 1.2 g∙kg-1∙d-1 fat) including CHO before/during/after workouts (HCHO, n = 8): similar macronutrient intake periodised within/between days to manipulate low and high CHO availability at various workouts (PCHO, n = 8); and LCHF (<50 g∙d-1 CHO; 78% energy as fat; 2.1 g∙kg-1∙d-1 protein; n = 10). After Adapt, all athletes resumed HCHO for 2.5 wk before a cohort (n = 19) completed a 20 km race.
Results: All groups increased VO2peak (ml∙kg-1∙min-1) at Adapt (p = 0.02, 95%CI: [0.35-2.74]). LCHF markedly increased whole-body fat oxidation (from 0.6 g∙min-1 to 1.3 g∙min-1), but also the oxygen cost of walking at race-relevant velocities. Differences in 10,000 m performance were clear and meaningful: HCHO improved by 4.8% or 134 s (95% CI: [207 to 62 s]; p < 0.001), with a trend for a faster time (2.2%, 61 s [-18 to +144 s]; p = 0.09) in PCHO. LCHF were slower by 2.3%, -86 s ([-18 to -144 s]; p < 0.001), with no evidence of superior "rebound" performance over 20 km after 2.5 wk of HCHO restoration and taper.
Conclusion: Our previous findings of impaired exercise economy and performance of sustained high-intensity race walking following keto-adaptation in elite competitors were repeated. Furthermore, there was no detectable benefit from undertaking an LCHF intervention as a periodised strategy before a 2.5-wk race preparation/taper with high CHO availability.
Trial Registration: Australia New Zealand Clinical Trial Registry: ACTRN12619000794101.
Competing Interests: The authors have declared that no competing interests exist

Erratum in: PLoS One. 2020 Jun 26;15(6):e0235592. (PMID: 32589685)

Metabolism. 2016 Mar;65(3):100-10. (PMID: 26892521)
Biochem J. 1920 Jul;14(3-4):290-363. (PMID: 16742941)
Sports Med. 2018 Apr;48(4):1009-1019. (PMID: 29143929)
Med Sci Sports Exerc. 2017 Dec;49(12):2486-2497. (PMID: 28723843)
Med Sci Sports Exerc. 2019 Dec;51(12):2506-2515. (PMID: 31730565)
J Physiol. 2017 May 1;595(9):2857-2871. (PMID: 27861911)
Int J Sport Nutr Exerc Metab. 2018 Sep 1;28(5):451-463. (PMID: 30249148)
Novartis Found Symp. 2007;280:108-21; discussion 121-7, 160-4. (PMID: 17380791)
Nutrients. 2019 Jan 24;11(2):. (PMID: 30682843)
Can J Sport Sci. 1991 Mar;16(1):23-9. (PMID: 1645211)
Science. 2018 Nov 16;362(6416):781-787. (PMID: 30442803)
FASEB J. 2018 Jun;32(6):2979-2991. (PMID: 29401600)
Br J Sports Med. 2014 Jul;48(14):1077-8. (PMID: 24861453)
J Appl Physiol (1985). 2020 Feb 1;128(2):440-444. (PMID: 31917623)
Annu Rev Nutr. 2018 Aug 21;38:303-328. (PMID: 30130468)
Med Sci Sports Exerc. 2002 Jan;34(1):83-91. (PMID: 11782652)
Free Radic Biol Med. 2009 Apr 15;46(8):1068-75. (PMID: 19439233)
J Appl Physiol (1985). 2000 Dec;89(6):2413-21. (PMID: 11090597)
Sports Med. 2018 Oct;48(10):2219-2226. (PMID: 29777386)
Am J Physiol Endocrinol Metab. 2006 Feb;290(2):E380-8. (PMID: 16188909)
PLoS Med. 2005 Aug;2(8):e124. (PMID: 16060722)
Cell Metab. 2016 Aug 9;24(2):256-68. (PMID: 27475046)
Eur J Sport Sci. 2015;15(1):13-20. (PMID: 25275931)
Sports Med. 2020 Apr;50(4):641-656. (PMID: 31820376)
Comp Biochem Physiol A Mol Integr Physiol. 2003 Sep;136(1):161-70. (PMID: 14527638)
Int J Sports Med. 2017 Nov;38(13):975-982. (PMID: 29050040)
Int J Sports Physiol Perform. 2010 Dec;5(4):521-34. (PMID: 21266736)
Sports Med. 2018 May;48(5):1031-1048. (PMID: 29453741)
J Sci Med Sport. 2019 Jun;22(6):702-706. (PMID: 30553764)
Med Sci Sports Exerc. 2019 Oct;51(10):2135-2146. (PMID: 31033901)
Sports Med. 2010 Sep 1;40(9):747-63. (PMID: 20726621)
Metabolism. 1983 Aug;32(8):769-76. (PMID: 6865776)
J Sports Sci. 2019 Mar;37(5):553-559. (PMID: 30207506)
Med Sci Sports Exerc. 2016 Mar;48(3):543-68. (PMID: 26891166)
Med Sci Sports Exerc. 2018 Nov;50(11):2330-2338. (PMID: 29944604)
Eur J Appl Physiol. 2015 Dec;115(12):2521-30. (PMID: 26335627)
Front Physiol. 2019 Feb 11;10:79. (PMID: 30804807)
Med Sci Sports Exerc. 1992 Apr;24(4):483-9. (PMID: 1560747)
Metabolism. 2018 Apr;81:25-34. (PMID: 29108901)
J Appl Physiol (1985). 2017 May 1;122(5):1077-1087. (PMID: 27909225)
Int J Sport Nutr Exerc Metab. 2019 Mar 1;29(2):117-129. (PMID: 30747558)
J Appl Physiol Respir Environ Exerc Physiol. 1983 Aug;55(2):628-34. (PMID: 6618956)
Med Sci Sports Exerc. 2002 Jan;34(1):92-7. (PMID: 11782653)
Int J Sport Nutr Exerc Metab. 2018 Sep 1;28(5):480-489. (PMID: 29431534)
Nat Hum Behav. 2017 Jan 10;1:0021. (PMID: 33954258)
Front Physiol. 2018 May 23;9:599. (PMID: 29875697)
J Sports Sci. 1990 Spring;8(1):35-45. (PMID: 2359150)
Int J Sports Physiol Perform. 2018 Aug 1;13(7):957-960. (PMID: 29252062)
J Physiol. 2008 Jan 1;586(1):35-44. (PMID: 17901124)
Med Sci Sports Exerc. 2016 Apr;48(4):663-72. (PMID: 26741119)
J Physiol. 2017 May 1;595(9):2989. (PMID: 28452138)
Metabolism. 1999 Dec;48(12):1509-17. (PMID: 10599981)
Front Physiol. 2017 Oct 23;8:806. (PMID: 29109686)
J Physiol. 2017 May 1;595(9):2785-2807. (PMID: 28012184)
J Appl Physiol (1985). 2006 Jan;100(1):194-202. (PMID: 16141377)
Front Endocrinol (Lausanne). 2020 Jan 21;10:880. (PMID: 32038477)
Sports Med. 2014 May;44 Suppl 1:S87-96. (PMID: 24791920)
Int J Sports Med. 2014 Mar;35(3):265-9. (PMID: 24022570)
J Physiol. 2016 Aug 1;594(15):4389-405. (PMID: 26918583)
Nutrients. 2019 Mar 13;11(3):. (PMID: 30871219)
Handb Exp Pharmacol. 2014;225:149-57. (PMID: 25304531)
J Appl Physiol (1985). 2006 Jan;100(1):7-8. (PMID: 16357078)
J Physiol. 2021 Feb;599(3):819-843. (PMID: 32358802)
PLoS Biol. 2016 Jan 04;14(1):e1002333. (PMID: 26726926)
J Sports Sci. 1991 Summer;9 Spec No:29-51; discussion 51-2. (PMID: 1895362)
Sports Med. 2018 Oct;48(10):2421-2422. (PMID: 30120725)
J Physiol. 2017 May 1;595(9):2993-2994. (PMID: 28452135)
Med Sci Sports Exerc. 2010 Feb;42(2):394-401. (PMID: 19927018)
Am J Physiol. 1992 Jul;263(1 Pt 1):E64-71. (PMID: 1636700)
Eur J Appl Physiol Occup Physiol. 1994;69(4):287-93. (PMID: 7851362)
Eur J Sport Sci. 2015;15(1):3-12. (PMID: 24942068)

ANZCTR ACTRN12619000794101

Date Created: 20200605 Date Completed: 20200821 Latest Revision: 20231111

20240104

PMC7272074

10.1371/journal.pone.0234027

32497061